Life Science REIT stock drops after reporting NTA decline

Published 28/07/2025, 10:00
 Life Science REIT stock drops after reporting NTA decline

Investing.com -- Life Science REIT PLC stock fell 8% after the company reported a 10.9% decline in its unaudited EPRA Net Tangible Assets (NTA) for the first half of 2025.

The company’s NTA decreased to £232.1 million or 66.3 pence per share as of June 30, 2025, down from £260.4 million or 74.4 pence per share at the end of December 2024.

LABS also disclosed a minor technical covenant breach on its projected interest cover ratio test. The company reported a cover test result of 193.1% against the required threshold of 200%, but has secured a waiver from its lenders.

Despite the NTA decline, LABS noted some operational improvements during 2025, including signing leases with four new occupiers. This increased contracted rent to £17.4 million from £15.9 million at the end of 2024, while occupancy rose slightly to 85.1% from 84.4%.

The company also announced a redesign of buildings 10 and 11 at its OTP development, creating seven smaller units instead of two large ones. This change, which comes with an additional cost of £5.0 million, is expected to increase the overall estimated rental value (ERV) on these buildings by £0.35 million to £2.1 million, reflecting higher demand for small to mid-sized units with an ERV of £25 per square foot.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.